ZANIDIP

This brand name is authorized in Australia, Austria, Brazil, Finland, France, Hong Kong SAR China, Ireland, Mexico, South Africa, Spain, Tunisia, UK.

Active ingredients

The drug ZANIDIP contains one active pharmaceutical ingredient (API):

1	Lercanidipine UNII OA8TFX68PE - LERCANIDIPINE HYDROCHLORIDE
	Lercanidipine is a calcium antagonist of the dihydropyridine group and inhibits the transmembrane influx of calcium into cardiac and smooth muscle. The mechanism of its antihypertensive action is due to a direct relaxant effect on vascular smooth muscle thus lowering total peripheral resistance.
	Read more about Lercanidipine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ZANIDIP Film-coated tablet	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C08CA13	Lercanidipine	C Cardiovascular system → C08 Calcium channel blockers → C08C Selective calcium channel blockers with mainly vascular effects → C08CA Dihydropyridine derivatives
Discover more medicines within C08CA13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	8534E, 8679T
BR	Câmara de Regulação do Mercado de Medicamentos	525012040100703, 525014040104303, 525014040104403
ES	Centro de información online de medicamentos de la AEMPS	61653, 65379
FI	Lääkealan turvallisuus- ja kehittämiskeskus	013353, 013399, 563569, 585786
FR	Base de données publique des médicaments	66394873, 69025707
GB	Medicines & Healthcare Products Regulatory Agency	101988, 13674, 147655, 147657, 164493
HK	Department of Health Drug Office	47384, 61340
IE	Health Products Regulatory Authority	55849, 63804, 63815
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	135M2002
TN	Direction de la Pharmacie et du Médicament	7313082, 9024208
ZA	Health Products Regulatory Authority	33/7.1/0113, A40/7.1/0106